Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: 4 | Mind Blowing Facts

Izotropic Finalizes Engineering and Development Transition to the United States; Establishes Operations in Primary Target Market

VANCOUVER, BC – TheNewswire - August 11, 2022 – Izotropic Corporation ("Izotropic" or the "Company") (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a MedTech company commercializing IzoView, an advanced three-dimensional computed tomography (3D CT) breast imaging platform for the more accurate detection and diagnosis of breast cancer, is pleased to report the Company has successfully…

Benzinga · Aug 16, 2022

'There's never been a better time to work in a region and develop a startup'

'There's never been a better time to work in a region and develop a startup'

The Accelerator program offers a deep dive into business development for startups

Newcastle Herald · Aug 2, 2022

Headache-busting balloon injected via NOSTRIL among 7 pioneering new NHS treatments

Headache-busting balloon injected via NOSTRIL among 7 pioneering new NHS treatments

Among seven new pioneering NHS treatments are an injection of an enlarged prostate with jets of steam to shrink it, a portable chest drainage device for heart and lung problems and an automated blood cell replacement system

Daily Mirror · Mar 24, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Surgical Robot Maker Memic Terminates SPAC Merger

Memic Innovative Surgery Ltd has pulled out of a reverse merger deal with MedTech Acquisition Corporation (NASDAQ:MTAC), a special purpose acquisition company (SPAC) focused on medical technology. Last August, Memic announced its merger with MedTech Acquisition Corporation to take the surgical robot public. As of this week, however, the deal is off. Memic is a developer of…

Benzinga · Mar 11, 2022

5 Beaten-Down Medtech Stocks to Buy on the Dip

Because record-high inflation and expected interest rate hikes are roiling the equity markets, it could be wise to buy MedTech stocks due to the industry's solid growth prospects and a near-inelastic demand for MedTech products with rising health awareness. So, we believe quality MedTech company stocks ResMed (RMD), Merit Medical…

StockNews.com · Feb 9, 2022

1 2 3 4

Coverage From

People

Amanda Pritchard

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

424,417 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play